Catalyst
Slingshot members are tracking this event:
Affimed (AFMD) Presents Initial Data from Phase 1 Study of Cord Blood-derived Natural Killer Cells Pre-complexed with Innate Cell Engager AFM13
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| AFMD | Community voting in process | |||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Apr 13, 2021
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Nk Therapy, Afm13
